Cough, Cold and Allergy (Hay Fever) Remedies

The COVID-19 outbreak resulted in consumers becoming more conscious of health, and adopting more effective measures to eliminate flu and cold symptoms. This led to increased demand for cough, cold and allergy remedies, particularly prior to the ...

In 2020, cough, cold and allergy (hay fever) remedies is expected to see higher current value growth than in the previous year. Although sales of such products increased significantly during panic-buying in March and April due to COVID-19, demand saw...

Cough, cold and allergy (hay fever) remedies is expected to be largely unaffected by COVID-19, with similar healthy double-digit value growth as 2019. However, part of this growth in 2020 is driven by inflation as a result of the economic effect of ...

There was a strong upsurge in demand for cough, cold and allergy (hay fever) remedies in the first quarter of 2020 at the peak of the pandemic. In the second quarter demand normalised as consumers went through their stock of cough, cold and allergy ...

COVID-19 was a mixed blessing for cough, cold and allergy (hay fever) remedies in Latvia in 2020. Each year the sales performance for cough, cold and allergy (hay fever) remedies is highly dependent on the incidence of seasonal malaises. Therefore, ...

Value sales of cough, cold and allergy (hay fever) remedies increased in early 2020 as a result of health-conscious consumers stocking up on medicines in case they were needed to combat the symptoms of the COVID-19 virus. Although demand has ...

Panic and fear caused by the outbreak of COVID-19 has provoked Moroccan consumers to stockpile many products in cough, cold and allergy (hay fever) remedies. In most cases, consumer decision making was based on future precaution rather than specific ...

The COVID-19 pandemic has strongly impacted current retail value sales of cough, cold and allergy products in 2020. Stockpiling occurred at the start of lockdown as consumers made sure they had large enough supplies of these products for themselves ...

Growth in cough, cold and allergy (hay fever) remedies in Tunisia is supported by a number of factors. Firstly, Tunisian consumers’ propensity to self-medicate for minor ailments, purchasing OTC products from pharmacists instead of seeking medical ...

Typically, sales of cough, cold and allergy (hay fever) remedies are highly dependent on the season as it is used to combat flu. Sales in 2020 were boosted due to fear of contracting COVID-19 as well as increasing desire to self-medicate due to ...

Similarly to analgesics, the impact of COVID-19 on cough, cold and allergy (hay fever) remedies was mostly felt during the first two months after the initial lockdown was announced and implemented on 18 March by local health authorities. During this ...

Cold, cough and allergy (hay fever) remedies are expected to register double-digit value growth in 2020, though not as high as value growth over the review period. However, a lot of value growth over the review period has been driven by inflationary ...

The demand for cough/cold remedies increased strongly in the early stages of Coronavirus (COVID-19) in Poland. Sales spiked as consumers panicked about possible shortages of these products in retail stores. The perception that these medicines offered...

The COVID-19 outbreak is anticipated to largely benefit cough, cold, allergy (hay fever) remedies in 2020 overall, with current value sales growing notably. Prior to the pandemic, seasonal flus and colds were the main drivers of growth and this has ...

In 2020 cough, cold and allergy (hay fever) remedies will benefit from Ukrainians panic-buying such products, fearing shortages during the COVID-19 lockdown. This is despite the worsening economic situation and weakening consumer spending power. ...

Cough, cold and allergy (hay fever) remedies will see a sharp deceleration in value sales growth during 2020 due to the impact of COVID-19. As a result of the country’s long and cold winters, consumer demand for cough, cold and allergy (hay fever) ...

As with analgesics, consumers in Q1 and Q2 bought cough and cold remedies due to the outbreak of COVID-19, to ward off any symptoms. The impact of this will see growth move to 1% in 2020, up from a decline in 2019. Most of this value growth is ...

The similarity between the symptoms of seasonal colds and COVID-19 is expected to drive sales of cough, cold and allergy (hay fever) remedies in 2020, as the retail current value growth is set to peak. Combination products – cough, cold and allergy ...

The stay at home mandate in force in Romania from 24 March, dramatically reduced the number of cough and cold cases, and thus lowered demand for remedies. Equally, the social distancing measures in place and the ban on public gatherings of large ...

The advent of COVID-19 has enhanced the already very strong rise in demand for cough, cold and allergy (hay fever) remedies in Turkey. Many products under this category are recommended for tackling symptoms of COVID-19, such as Imuneks and Umca, both...